Puma Biotechnology Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

PBYI 104.05 -1.45 (-1.37%)
price chart
Puma Biotechnology Faces Balance Sheet Anxiety
Puma Biotechnology, Inc. (PBYI), a $4.7b market cap biotechnology company, reported better than expected revenue and significantly worse EBITDA for its 3Q17 ended September 30 after the market close on October 9. Puma's 3Q17 revenue of $6.08m was ...
Puma Biotechnology Is Down 19% -- Is Its Stock a Bargain?  Motley Fool
Puma Biotechnology Inc (PBYI) Plunges 19.03% on November 10  Equities.com
Puma Biotechnology Continues To Thrive Despite European Debacle
Puma Biotechnology, Inc. (NASDAQ:PBYI) got approval for neritinib, or Nerlynx, a tyrosine kinase inhibitor that blocks HER1, HER2, HER3 and HER4, and is approved for the extended adjuvant treatment of early-stage, HER2-positive breast cancer in adult ...
Puma Biotechnology Inc (PBYI) Breaks into New 52-Week High on November 06 ...  Equities.com
Should You Buy Puma Biotechnology (PBYI) Ahead of Earnings? November 08, 2017  Zacks.com
Dissecting the Investment Cases for Puma Biotechnology, Inc. (PBYI) and ...
Puma Biotechnology, Inc. (NASDAQ:PBYI) and Halozyme Therapeutics, Inc. (NASDAQ:HALO) are both Healthcare companies that recently hit new low.
Analysts Suggest to Buy Healthcare Stock: Puma Biotechnology, Inc. (PBYI)  Street Observer (press release)
Puma Biotechnology Inc (PBYI) Price Target Lowered to $92.00 at Royal Bank ...  TrueBlueTribune
The Volatility Option Trade After Earnings in Puma Biotechnology Inc
This is a slightly advanced option trade that bets on volatility for a period that starts one-day after Puma Biotechnology Inc (NYSE:PBYI) earnings and lasts for the 6 calendar days to follow, that has been a winner for the last 3 years. We note the ...
Puma Biotechnology Inc (PBYI) Moves Lower on Volume Spike for November 13
Puma Biotechnology Inc (PBYI) traded on unusually high volume on Nov. 13, as the stock lost 1.84% to close at $101.10. On the day, Puma Biotechnology Inc saw 1.68 million shares trade hands on 15,256 trades. Considering that the stock averages only a ...
Puma Biotechnology Inc (PBYI) Rating Lowered to Buy at BidaskClub  Newburgh Gazette
Zacks: Analysts Anticipate Puma Biotechnology Inc (PBYI) Will Post Earnings ...  The Ledger Gazette
Puma Biotechnology Inc (NYSE:PBYI) Releases Earnings Results, Beats Estimates ...
Puma Biotechnology logo Puma Biotechnology Inc (NASDAQ:PBYI) released its earnings results on Thursday, November 9th. The biopharmaceutical company reported ($2.07) EPS for the quarter, topping the Zacks' consensus estimate of ($2.50) by $0.43, ...
Comparing Puma Biotechnology, Inc. (PBYI) and FibroGen, Inc. (FGEN)  StockNewsGazette
Puma Biotechnology Inc (PBYI) Price Target Increased to $164.00 by Analysts ...  TrueBlueTribune
Puma Biotechnology Secures $100 Million Term Loan from Silicon Valley Bank and ...
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, has entered into a loan agreement with Silicon Valley Bank, the bank of the world's most innovative companies and their investors, and Oxford ...
Former Puma Biotech executive pleads guilty to insider trading  Reuters
Puma Biotechnology, Inc. (NASDAQ: PBYI) – Analysts' Recommendation in Spotlight
Asian shares fell in muted trading Monday ahead of the Thanksgiving holidays in the U.S., as gloom carried over from Friday's retreat on Wall Street.
Puma Biotechnology's 5-Year Analysis of Phase III ExteNET Study Published ...
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced the publication of previously presented results from the ExteNET Phase III clinical trial of Puma's drug neratinib in patients with early ...
Puma Biotechnology Inc (PBYI) Breaks into New 52-Week High on October 31 Session
Shares of Puma Biotechnology Inc (PBYI) broke into a new 52-week high yesterday, hitting a peak of $131.00. Shares closed at $127.30 after opening at $129.10 for a move of -0.62%.
Puma Biotechnology to Host Conference Call to Discuss Third Quarter ...  Business Wire (press release)
Why You Should Not Give Up On Puma Biotechnology, Inc. (PBYI), Jazz ...  Post Analyst